CBER - Office of Blood Research and Review - Organization - Text version
The following header reflects the organizational hierarchy.
FOOD AND DRUG ADMINISTRATION
OFFICE OF MEDICAL PRODUCTS AND TOBACCO
CENTER FOR BIOLOGICS EVALUATION AND RESEARCH
OFFICE OF BLOOD RESEARCH AND REVIEW
The following is the communication box containing information to assist anyone who may want to communicate with the depicted organization via telephone, facsimile or mail.
WOC1 Bldg Rm 411N
1401 Rockville Pike
Rockville, MD 20852
The following is the Food and Drug Administration, Office of Medical Products and Tobacco, Center for Biologics Evaluation and Research, Office of Blood Research and Review organization structure depicting all the organizational structures reporting to the Office Director. These organizational structures are organized in sequential order by their assigned Standard Administrative code (Alphanumeric sequence of characters beginning with the letter D).
Each organizational component will be depicted in the following standard format:
Title of organization.
Position title of the manager.
Military rank if any, first name, middle initial if any, last name, post graduate degrees if any, and if the individual is designated as acting.
Standard Administrative code.
Jay S. Epstein, M.D.
Reports directly to the Office Director
Ginette Y. Michaud, M.D.
Senior Advisor for Scientific Affairs
Mark J. Weinstein, Ph.D.
ASSOCIATE DIRECTOR FOR POLICY AND COMMUNICATIONS
Jennifer B. Scharpf, M.P.H.
Deputy Director for Operations and Regulatory Affairs
Alan E. Williams, Ph.D.
Associate Director For Research
Chintamani D. Atreya, Ph.D.
Associate Director for Medical Affairs
Basil Golding, M.D. (Acting)
Associate Deputy Director for Quality Assurance
Joseph Giglio, M.S.
Deputy Associate Director for Bioinformatics
Deputy Associate Director for Regulatory Affairs
Betsy Jett, B.S.
Approved by the FDA Reorganization Coordinator and Principal Delegation Control Officer